These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 19561643)
1. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643 [TBL] [Abstract][Full Text] [Related]
2. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168 [TBL] [Abstract][Full Text] [Related]
3. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition. Ren D; Minami Y; Nishita M Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370 [TBL] [Abstract][Full Text] [Related]
4. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells. Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592 [TBL] [Abstract][Full Text] [Related]
5. Insight into the role of Wnt5a-induced signaling in normal and cancer cells. Endo M; Nishita M; Fujii M; Minami Y Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716 [TBL] [Abstract][Full Text] [Related]
7. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598 [TBL] [Abstract][Full Text] [Related]
8. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266 [TBL] [Abstract][Full Text] [Related]
9. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005 [TBL] [Abstract][Full Text] [Related]
10. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling. Wan J; Liu Y; Long F; Tian J; Zhang C Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2. Vaidya H; Rumph C; Katula KS PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652 [TBL] [Abstract][Full Text] [Related]
12. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008 [TBL] [Abstract][Full Text] [Related]
13. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508 [TBL] [Abstract][Full Text] [Related]
14. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Yamamoto H; Oue N; Sato A; Hasegawa Y; Yamamoto H; Matsubara A; Yasui W; Kikuchi A Oncogene; 2010 Apr; 29(14):2036-46. PubMed ID: 20101234 [TBL] [Abstract][Full Text] [Related]
15. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway. Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412 [TBL] [Abstract][Full Text] [Related]
16. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis. Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384 [TBL] [Abstract][Full Text] [Related]
17. Wnt5A activates the calpain-mediated cleavage of filamin A. O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143 [TBL] [Abstract][Full Text] [Related]
18. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3. Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612 [TBL] [Abstract][Full Text] [Related]
19. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex. Endo M; Doi R; Nishita M; Minami Y J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498 [TBL] [Abstract][Full Text] [Related]
20. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]